Skip to main content
An official website of the United States government

adenoviral vector encoding VEGF-C LX-1101

A genetically engineered, replication-deficient adenovirus carrying the gene encoding for the human vascular endothelial growth factor C (VEGFC; VEGF-C; Flt4 ligand), with potential pro-angiogenic activity. Upon perinodal administration of the AdAptVEGF-C adenoviral vector LX-1101, the adenovirus infects cells and promotes expression of VEGF-C. In turn, VEGF-C induces vascular and lymphatic endothelial cell proliferation locally, and may help re-grow the lymphatic system and improve symptoms associated with lymphedema (LE). VEGF-C, a lymphatic growth factor, plays a key role in (lymph)angiogenesis and the functioning of the lymphatic system.
Synonym:AdAptVEGF-C adenoviral vector LX-1101
VEGFC-expressing gene therapeutic LX-1101
Foreign brand name:Lymfactin
Code name:LX 1101
LX-1101
LX1101
Search NCI's Drug Dictionary